Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

A study shows that loss of key metabolic enzymes increases oxidative stress and precancerous lesions in the pancreas. These ...

Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team headed by Helmholtz Munich and the German Center for Diabetes Research (DZD ...

Microscopic image with a star-shaped lumen on the left and a spherical lumen on the right. The apical marker Ezrin shown in green marks the lumen surface. Tissue engineering the pancreas: Working with ...

Led by Santé, the funding will support completion of the world's first randomized HIFU trial for pancreatic cancer, and accelerate U.S. clinical programs for the company's anesthesia-free, outpatient ...

The gene Pdx-1 is thought to be the pancreatic master switch because it is one of the first genes to be expressed during pancreatic development. Reporting in the 15 February Genes & Development, ...

Attendees at the AACR Annual Meeting 2026 can meet with ClearNote Health's scientific leaders, including newly appointed Chief Medical Officer, Jeffrey Venstrom, MD. At booth 3448 ...

Company to participate in Live Virtual Investor Closing Bell segment today, April 16th at 4:00 PM ET; Register for the event hereOCALA, Fla., ...

ClearNote Health announced a lineup of presentations at the upcoming annual meeting of the American Association for Cancer ...